Detall de la convocatòria
Característiques
| Característica |
|---|
|
Objectiu de la convocatòria
Support for innovative small molecule and biologic (antibodies, oligonucleotides, peptides, gene therapy etc.) drug development programs for FTD. Drug targets in the areas of inflammation and proteostasis will be considered high priority. |
|
Característiques principals
The RFP supports: This RFP does NOT support target identification, target validation, assay development, high-throughput and high-content screening. IND-enabling work is supported through ADDF’s PACT RFP. |
|
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a: Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.05.76. Marta López: mlopez4@imim.es Ext.: 1576 Carol Barnwell: cbarnwell@imim.es Ext.: 1670 |
|
Convocatòria (URL)
https://www.alzdiscovery.org/research-and-grants/funding-opportunities/accelerating-drug-discovery-for-ftd Applications: https://addf.fluxx.io/ |
|
Dotació
$300,000-$350,000 based on stage and scope of research. Slightly higher budgets can be considered. |
|
Durada
One year with potential for follow-on funding. |
|
AVÍS IMPORTANT
Letter of Intent: May13th, 2024 Invited Full Proposal: July 22th, 2024 |